18. Knoops, K. T. B., et al., “Mediterranean Diet, Lifestyle Factors, and 10-Year Mortality in Elderly European Men and Women—The HALE Project,”
19. Oldways Trust Mediterranean Diet Foundation US, “Mediterranean Diet: The Scientific Evidence” (2009). (Accessed March 15, 2009, at http://www.oldwayspt.org/.)
20. Sofi, F., “Adherence to Mediterranean Diet and Health Status: Meta-Analysis,”
21. Owen, R. W., Haubner, R., Wurtele, G., Hull, E., Spiegelhalder, B., Bartsch, H., “Olives and Olive Oil in Cancer Prevention,”
22. Martin-Moreno, J. M., et al., “Dietary Fat, Olive Oil Intake and Breast Cancer Risk,”
23. Stoneham, M., et al., “Olive Oil, Diet and Colorectal Cancer: An Ecological Study and a Hypothesis,”
24. Lipworth, L., et al., “Olive Oil and Human Cancer: An Assessment of the Evidence,”
25. Menendez, J. A., et al., “Oleic Acid, the Main Monounsaturated Fatty Acid of Olive Oil, Suppresses Her-2/neu (erbB-2) Expression and Synergistically Enhances the Growth Inhibitory Effects of Trastuzumab (Herceptin) in Breast Cancer Cells with Her-2/neu Oncogene Amplification,”
26. Menendez, J. A., et al., “Analyzing Effects of Extra-Virgin Olive Oil Polyphenols on Breast Cancer-Associated Fatty Acid Synthase Protein Expression Using Reverse-Phase Protein Microarrays,”
27. Wu, A. H., M. C. Pike, and D. O. Stram, “Meta-analysis: Dietary Fat Intake, Serum Estrogen Levels, and the Risk of Breast Cancer,”
28. Ravdin, P. M., K. A. Cronin, N. Howlader, et al., “The Decrease in Breast-Cancer Incidence in 2003 in the United States,”
29. Agence Française de Sécurité Sanitaire des Aliments,
30. Aggarwal, B. B., H. Ichikawa, P. Garodia, et al., “From Traditional Ayurvedic Medicine to Modern Medicine: Identification of Therapeutic Targets for Suppression of Inflammation and Cancer,”
31. Ferlay, J., F. Bray, P. Piesci, et al., eds., WHO International Agency for Research on Cancer (IARC), IARC Cancer Epidemiology Database, Globocan 2000,
32. Institute for Scientific Information, isihighlycited.com, 2005.
33. Shishodia, S., and B. B. Aggarwal, “Nuclear Factor-kappaB Activation: A Question of Life or Death,”
34. Mehta, K., P. Pantazis, T. McQueen, et al., “Antiproliferative Effect of Curcumin (Diferuloylmethane) Against Human Breast Tumor Cell Lines,”
35. Aggarwal, B. B., S. Shishodia, Y. Takada, et al., “Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-kappaB Pathway in Breast Cancer Cells and Inhibits Lung Metastasis of Human Breast Cancer in Nude Mice,”
36. Carter, A., “Curry Compound Fights Cancer in the Clinic,”
37. Cheng, A. L., C. H. Hsu, J. K. Lin, et al., “Phase I Clinical Trial of Curcumin, a Chemopreventive Agent, in Patients with High-Risk or Pre-malignant Lesions
38. Shoba, G., D. Joy, T. Joseph, et al., “Influence of Piperine on the Pharmacokinet ics of Curcumin in Animals and Human Volunteers,”
39. Gao, X., D. Deeb, H. Jiang, et al., “Curcumin Differentially Sensitizes Malignant Glioma Cells to TRAIL/Apo2L-Mediated Apoptosis Through Activation of Pro caspases and Release of Cytochrome c from Mitochondria,”
